Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the health-check domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /dom76025/wp-includes/functions.php on line 6121
March 22, 2024 - Page 5 of 6 - The Dermatology Digest
Search

One-on-One: TDD Talks to Paul Lizzul, MD, PhD, Chief Medical Officer, AnaptysBio

AnaptysBio is developing ANB032, an investigational B and T lymphocyte attenuator (BTLA) receptor agonist,  for the treatment of atopic dermatitis (AD). The Company recently presented preclinical data at the American Academy of Dermatology’s (AAD) annual meeting in San Diego, CA. Paul Lizzul, MD, PhD, Chief Medical Officer of AnaptysBio, spoke with the Dermatology Digest about […]